Benitec Biopharma Ltd Stock Price History
| BNTC Stock | USD 10.24 0.51 5.24% |
Below is the normalized historical share price chart for Benitec Biopharma Ltd extending back to June 23, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Benitec Biopharma stands at 10.24, as last reported on the 29th of November, with the highest price reaching 10.24 and the lowest price hitting 9.70 during the day.
If you're considering investing in Benitec Stock, it is important to understand the factors that can impact its price. Benitec Biopharma appears to be slightly risky, given 3 months investment horizon. Benitec Biopharma secures Sharpe Ratio (or Efficiency) of 0.0492, which signifies that the company had a 0.0492% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Benitec Biopharma Ltd, which you can use to evaluate the volatility of the firm. Please makes use of Benitec Biopharma's Mean Deviation of 3.27, downside deviation of 3.57, and Risk Adjusted Performance of 0.0349 to double-check if our risk estimates are consistent with your expectations.
At present, Benitec Biopharma's Common Stock Shares Outstanding is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 54.8 M, whereas Common Stock Total Equity is forecasted to decline to 855.00. . As of November 29, 2024, Price To Sales Ratio is expected to decline to 75.45. In addition to that, Price Earnings Ratio is expected to decline to -1.42. Benitec Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 18th of August 2015 | 200 Day MA 7.6405 | 50 Day MA 9.7691 | Beta 0.879 |
Benitec |
Sharpe Ratio = 0.0492
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BNTC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.76 actual daily | 42 58% of assets are more volatile |
Expected Return
| 0.23 actual daily | 4 96% of assets have higher returns |
Risk-Adjusted Return
| 0.05 actual daily | 3 97% of assets perform better |
Based on monthly moving average Benitec Biopharma is performing at about 3% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Benitec Biopharma by adding it to a well-diversified portfolio.
Price Book 3.5197 | Enterprise Value Ebitda 0.2655 | Price Sales 2.8 K | Shares Float 3.9 M | Wall Street Target Price 24 |
Benitec Biopharma Stock Price History Chart
There are several ways to analyze Benitec Stock price data. The simplest method is using a basic Benitec candlestick price chart, which shows Benitec Biopharma price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | October 18, 2024 | 11.48 |
| Lowest Price | September 13, 2024 | 8.15 |
Benitec Biopharma November 29, 2024 Stock Price Synopsis
Various analyses of Benitec Biopharma's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Benitec Stock. It can be used to describe the percentage change in the price of Benitec Biopharma from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Benitec Stock.| Benitec Biopharma Price Rate Of Daily Change | 1.05 | |
| Benitec Biopharma Price Action Indicator | 0.53 | |
| Benitec Biopharma Price Daily Balance Of Power | 0.94 |
Benitec Biopharma November 29, 2024 Stock Price Analysis
Benitec Stock Price History Data
The price series of Benitec Biopharma for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 has a statistical range of 3.33 with a coefficient of variation of 9.2. The prices are distributed with arithmetic mean of 9.82. The median price for the last 90 days is 9.81. The company had 1:17 stock split on 26th of July 2023. Benitec Biopharma issued dividends on 2019-11-18.| Open | High | Low | Close | Volume | ||
11/29/2024 | 9.73 | 10.24 | 9.70 | 10.24 | ||
11/29/2024 | 9.73 | 10.24 | 9.70 | 10.24 | ||
| 11/27/2024 | 9.86 | 9.98 | 9.70 | 9.73 | 23,338 | |
| 11/26/2024 | 10.01 | 10.23 | 9.76 | 9.85 | 21,006 | |
| 11/25/2024 | 10.48 | 10.60 | 10.12 | 10.15 | 23,639 | |
| 11/22/2024 | 10.20 | 10.49 | 9.88 | 10.49 | 22,263 | |
| 11/21/2024 | 10.41 | 10.51 | 9.99 | 10.20 | 32,281 | |
| 11/20/2024 | 10.10 | 10.93 | 9.78 | 10.66 | 62,201 | |
| 11/19/2024 | 9.38 | 10.12 | 9.10 | 9.88 | 39,121 | |
| 11/18/2024 | 10.65 | 10.65 | 9.36 | 9.58 | 41,719 | |
| 11/15/2024 | 10.31 | 10.78 | 10.31 | 10.68 | 45,347 | |
| 11/14/2024 | 10.59 | 10.64 | 10.25 | 10.40 | 49,302 | |
| 11/13/2024 | 10.80 | 10.80 | 10.30 | 10.44 | 26,189 | |
| 11/12/2024 | 10.65 | 10.89 | 10.00 | 10.87 | 46,721 | |
| 11/11/2024 | 10.75 | 10.75 | 10.31 | 10.74 | 33,805 | |
| 11/08/2024 | 10.52 | 10.60 | 10.40 | 10.58 | 24,418 | |
| 11/07/2024 | 10.49 | 10.98 | 10.40 | 10.76 | 27,700 | |
| 11/06/2024 | 10.78 | 10.78 | 10.38 | 10.49 | 49,291 | |
| 11/05/2024 | 10.70 | 10.80 | 10.31 | 10.32 | 30,950 | |
| 11/04/2024 | 10.91 | 10.91 | 10.50 | 10.80 | 31,941 | |
| 11/01/2024 | 10.49 | 10.93 | 10.30 | 10.92 | 43,361 | |
| 10/31/2024 | 10.50 | 10.57 | 10.40 | 10.51 | 13,902 | |
| 10/30/2024 | 10.83 | 10.83 | 10.55 | 10.56 | 13,684 | |
| 10/29/2024 | 10.71 | 10.85 | 10.71 | 10.83 | 11,073 | |
| 10/28/2024 | 10.82 | 10.92 | 10.70 | 10.72 | 15,872 | |
| 10/25/2024 | 11.00 | 11.00 | 10.70 | 10.99 | 20,571 | |
| 10/24/2024 | 10.64 | 11.05 | 10.64 | 10.93 | 18,339 | |
| 10/23/2024 | 10.57 | 10.99 | 10.57 | 10.73 | 34,314 | |
| 10/22/2024 | 11.05 | 11.11 | 10.52 | 10.69 | 49,232 | |
| 10/21/2024 | 11.48 | 11.48 | 10.72 | 11.09 | 90,573 | |
| 10/18/2024 | 11.22 | 11.54 | 10.66 | 11.48 | 59,871 | |
| 10/17/2024 | 10.33 | 11.35 | 10.04 | 11.22 | 51,996 | |
| 10/16/2024 | 10.26 | 10.52 | 9.81 | 9.81 | 34,544 | |
| 10/15/2024 | 10.49 | 11.54 | 9.76 | 9.81 | 40,848 | |
| 10/14/2024 | 11.00 | 11.55 | 10.13 | 10.16 | 72,125 | |
| 10/11/2024 | 9.86 | 11.05 | 9.81 | 10.86 | 31,491 | |
| 10/10/2024 | 9.32 | 9.85 | 9.25 | 9.81 | 26,252 | |
| 10/09/2024 | 9.20 | 9.50 | 9.20 | 9.26 | 12,826 | |
| 10/08/2024 | 9.38 | 9.77 | 9.09 | 9.46 | 49,353 | |
| 10/07/2024 | 9.40 | 9.85 | 9.19 | 9.63 | 36,532 | |
| 10/04/2024 | 9.90 | 10.26 | 8.49 | 9.48 | 51,561 | |
| 10/03/2024 | 10.40 | 10.61 | 9.12 | 9.81 | 41,535 | |
| 10/02/2024 | 11.23 | 11.40 | 10.00 | 10.20 | 49,054 | |
| 10/01/2024 | 9.20 | 12.89 | 9.20 | 10.98 | 177,733 | |
| 09/30/2024 | 9.24 | 9.25 | 8.92 | 9.19 | 5,880 | |
| 09/27/2024 | 8.62 | 9.33 | 8.62 | 9.23 | 35,758 | |
| 09/26/2024 | 8.99 | 8.99 | 8.50 | 8.79 | 17,841 | |
| 09/25/2024 | 9.14 | 9.15 | 8.65 | 8.80 | 19,609 | |
| 09/24/2024 | 9.01 | 9.25 | 8.92 | 8.94 | 14,553 | |
| 09/23/2024 | 9.30 | 9.34 | 8.56 | 8.88 | 14,886 | |
| 09/20/2024 | 8.80 | 9.30 | 8.20 | 9.30 | 71,369 | |
| 09/19/2024 | 8.77 | 8.77 | 8.36 | 8.63 | 14,731 | |
| 09/18/2024 | 8.60 | 9.02 | 8.30 | 8.36 | 23,952 | |
| 09/17/2024 | 8.76 | 9.05 | 8.35 | 8.40 | 12,372 | |
| 09/16/2024 | 8.38 | 9.10 | 8.23 | 8.42 | 40,181 | |
| 09/13/2024 | 8.37 | 8.70 | 8.06 | 8.15 | 16,814 | |
| 09/12/2024 | 8.76 | 8.76 | 8.10 | 8.16 | 18,839 | |
| 09/11/2024 | 8.64 | 8.86 | 8.25 | 8.44 | 17,042 | |
| 09/10/2024 | 9.01 | 9.24 | 8.75 | 8.75 | 15,895 | |
| 09/09/2024 | 8.82 | 9.05 | 8.66 | 8.87 | 11,576 | |
| 09/06/2024 | 8.66 | 9.02 | 8.65 | 9.02 | 9,037 |
About Benitec Biopharma Stock history
Benitec Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Benitec is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Benitec Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Benitec Biopharma stock prices may prove useful in developing a viable investing in Benitec Biopharma
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 4.1 M | 4.3 M | |
| Net Loss | -17.6 M | -18.5 M |
Benitec Biopharma Stock Technical Analysis
Benitec Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Diagnostics Now
Portfolio DiagnosticsUse generated alerts and portfolio events aggregator to diagnose current holdings |
| All Next | Launch Module |
Benitec Biopharma Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Benitec Biopharma's price direction in advance. Along with the technical and fundamental analysis of Benitec Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Benitec to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0349 | |||
| Jensen Alpha | 0.1321 | |||
| Total Risk Alpha | (0.55) | |||
| Sortino Ratio | 0.0104 | |||
| Treynor Ratio | 0.8577 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Benitec Stock analysis
When running Benitec Biopharma's price analysis, check to measure Benitec Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Benitec Biopharma is operating at the current time. Most of Benitec Biopharma's value examination focuses on studying past and present price action to predict the probability of Benitec Biopharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Benitec Biopharma's price. Additionally, you may evaluate how the addition of Benitec Biopharma to your portfolios can decrease your overall portfolio volatility.
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |